Michael J. Labarre - Net Worth and Insider Trading

Michael J. Labarre Net Worth

The estimated net worth of Michael J. Labarre is at least $10 Million dollars as of 2024-11-05. Michael J. Labarre is the SVP, CHIEF TECHNICAL OFFICER of Halozyme Therapeutics Inc and owns about 173,756 shares of Halozyme Therapeutics Inc (HALO) stock worth over $10 Million. Details can be seen in Michael J. Labarre's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Labarre has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael J. Labarre

To

Michael J. Labarre Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael J. Labarre owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .

Click here to see the complete history of Michael J. Labarre’s form 4 insider trades.

Insider Ownership Summary of Michael J. Labarre

Ticker Comapny Transaction Date Type of Owner
HALO Halozyme Therapeutics Inc 2024-10-16 SVP & Chief Technical Officer

Michael J. Labarre Latest Holdings Summary

Michael J. Labarre currently owns a total of 1 stock. Michael J. Labarre owns 173,756 shares of Halozyme Therapeutics Inc (HALO) as of October 16, 2024, with a value of $10 Million.

Latest Holdings of Michael J. Labarre

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HALO Halozyme Therapeutics Inc 2024-10-16 173,756 58.72 10,202,952

Holding Weightings of Michael J. Labarre


Michael J. Labarre Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael J. Labarre has made a total of 35 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 35 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 20,000 shares on October 16, 2024, which brought Michael J. Labarre around $1 Million.

Insider Trading History of Michael J. Labarre

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael J. Labarre Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael J. Labarre Ownership Network

Ownership Network List of Michael J. Labarre

No Data

Ownership Network Relation of Michael J. Labarre

Insider Network Chart

Michael J. Labarre Owned Company Details

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

Michael J. Labarre is the SVP & Chief Technical Officer of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include director & President and CEO Helen Torley , SVP & Chief Financial Officer Nicole Labrosse , and SVP & General Counsel Mark Howard Snyder .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, Michael J. Labarre made 17 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 280,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 200,000 shares made by Helen Torley , a net sale of 49,881 shares made by Matthew L. Posard , and a net sale of 35,000 shares made by Nicole Labrosse .

In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Halozyme Therapeutics Inc Insider Transactions

No Available Data

Michael J. Labarre Mailing Address

Above is the net worth, insider trading, and ownership report for Michael J. Labarre. You might contact Michael J. Labarre via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.